AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9132982
Drug: Oral metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral metronidazole (2 g as a single oral dose)
Trial: 3721054
Drug: RV11 (propionyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RV11 (propionyl erythromycin mercaptosuccinate) 500 mg oral dose
Trial: 29962591
Drug: Palonosetron 0.075
RxNorm normalized name: palonosetron 0.075 MG in 1.5 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron 0.075 mg i.v.
Trial: 29962591
Drug: Palonosetron 0.075
RxNorm normalized name: palonosetron 0.075 MG in 1.5 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron 0.075 mg and Dexamethasone 4 mg i.v.
Trial: 24989060
Drug: Duloxetine 20-120
RxNorm normalized name: duloxetine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 20-120 mg/day
Trial: 22393128
Drug: MTX and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTX and prednisone (10 mg/d)
Trial: 20141566
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose atorvastatin
Trial: 20141566
Drug: Usual dose
RxNorm normalized name: HYDROGEN PEROXIDE 5 mg in 100 mL TOPICAL LIQUID [USUALKLENZ DISINFECTANTSPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual dose of simvastatin
Trial: 16127109
Drug: Hospital in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital in the Home (HITH) treatment
Trial: 12789224
Drug: Cetirizine 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 0.25 mg/kg orally twice daily for 1 week
Trial: 10229311
Drug: Subcutaneous insulin:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous insulin: 0.1 IU/kg body weight/day of neutral protamine hagedorn (NPH) insulin once a day
Trial: 6574528
Drug: Dexamethasone administered
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone administered at 1900h
Trial: 6574528
Drug: Dexamethasone administered
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone administered at 2300h
Trial: 26654211
Drug: Cognitive therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive therapy (CT) for recurrent MDD, 12-14 weeks duration
Trial: 26654211
Drug: Continuation-phase CT
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuation-phase CT or clinical management plus double-blind fluoxetine or pill placebo for higher risk patients (n = 241, 83%)
Trial: 26654211
Drug: Continuation-phase therapy
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation-phase therapy
Trial: 11579985
Drug: Distraction (listening
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distraction (listening to an audiotape) during the first hour of exposure treatment
Trial: 11579985
Drug: Exposure without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exposure without distraction during the first hour of exposure treatment
Trial: 1725912
Drug: Verapamil 360
RxNorm normalized name: verapamil 360 mg/24 hours oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 360 mg/day
Trial: 1101614
Drug: etidocaine 1%
RxNorm normalized name: etidocaine 1% preservative-free injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etidocaine 1% with adrenaline (5 mug/ml)
Trial: 1101614
Drug: bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 0.5% with adrenaline (5 mug/ml)
Trial: 22587850
Drug: Tai chi
RxNorm normalized name: Ma Chi Xian
DrugBank: Purslane (DB14327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tai chi twice a week (TC2)
Trial: 20617220
Drug: Roughened implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roughened implant surfaces
Trial: 12606165
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg Cu/l solution
Trial: 12606165
Drug: <0.01 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: <0.01 mg Cu/l solution (control)
Trial: 7755076
Drug: Intravenous saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous saline solution containing a multivitamin preparation
Trial: 2159860
Drug: 360 mg
RxNorm normalized name: aspirin 360 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 360 mg gamma-linolenic acid
Trial: 2159860
Drug: Indistinguishable placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indistinguishable placebo capsules
Trial: 9954
Drug: Atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50 mg and 100 mg)
Trial: 6849754
Drug: Oxprenolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxprenolol (80 mg)
Trial: 29198872
Drug: ACB single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACB single injection with IV Dex 8 mg
Trial: 29198872
Drug: ACB single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACB single injection without IV Dex
Trial: 22800401
Drug: Omalizumab treatment
RxNorm normalized name: Omalizumab
DrugBank: Omalizumab (DB00043)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Omalizumab treatment for 6 months
Trial: 16095548
Drug: Epidural steroid
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural steroid injections (ESIs) with local anaesthetic
Trial: 30241561
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline injection)
Trial: 26815247
Drug: Epidural steroid
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural steroid injections (ESIs)
Trial: 12189359
Drug: Nelfinavir 1250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nelfinavir 1250 mg twice a day plus low doses of ritonavir (100 mg)
Trial: 12189359
Drug: Nelfinavir 1250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nelfinavir 1250 mg twice a day plus low doses of ritonavir (200 mg)
Trial: 2945499
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg loratadine
Trial: 7547368
Drug: Antihypertensive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive therapy withdrawal
Trial: 7547368
Drug: Antihypertensive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive therapy with anticoagulant therapy
Trial: 1953230
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of various conventional antirheumatic drugs
Trial: 7284971
Drug: Moderate-dose (4000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-dose (4000 rads) radiation + 5-fluorouracil (5-FU)
Trial: 7284971
Drug: High-dose (6000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (6000 rads) radiation + 5-fluorouracil (5-FU)
Trial: 7284971
Drug: High-dose (6000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (6000 rads) radiation alone
Trial: 27085323
Drug: nab-Paclitaxel (nab-P)
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: nab-Paclitaxel (nab-P) 125 mg/m² + Gemcitabine (Gem) 1000 mg/m²
Trial: 27085323
Drug: Gemcitabine (Gem)
DrugBank: Gemcitabine (DB00441)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Gemcitabine (Gem) 1000 mg/m²
Trial: 25129475
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anesthesia with target-controlled infusion (TIVA-TCI)
Trial: 25129475
Drug: Balanced inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balanced inhalation anaesthesia (BAL)
Trial: 15897583
Drug: Flaxseed muffin
RxNorm normalized name: FLAXSEED
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed muffin (25 g daily)
Trial: 12413616
Drug: Mifepristone 200
RxNorm normalized name: mifepristone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 200 mg followed by misoprostol 800 microg vaginally on the same day
Trial: 2878457
Drug: 0.54 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.54 g/kg ethanol
Trial: 2878457
Drug: 0.3 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 g/kg ethanol
Trial: 24670314
Drug: NMES intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NMES intervention followed by conventional treatment (thermaltactile stimulation with intensive repetition of a dry-swallow task)
Trial: 24670314
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment without NMES
Trial: 21034484
Drug: Histamine-2-receptor antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine-2-receptor antagonists (H2RA)
Trial: 8136599
Drug: 1% lidocaine
RxNorm normalized name: Icy Hot Max 4%-1% Lidocaine Pain Relief Dry Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% lidocaine solution
Trial: 18326251
Drug: 0.2% ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% ropivacaine solution
Trial: 12410512
Drug: Lidocaine 2%
RxNorm normalized name: LIDOCAINE 2% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 2% (5-25 ml) for local anesthesia of the groin
Trial: 10220626
Drug: Lidocaine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (4 boluses of 50 mg each every 2 minutes, then an infusion of 3 mg/min for 12 hours, then 2 mg/min for 36 hours)
Trial: 7016629
Drug: Budesonide 0.025%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 0.025% ointment
Trial: 7016629
Drug: Budesonide 0.01%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 0.01% ointment (maintenance treatment)
Trial: 7016629
Drug: Betamethasone-17-valerate 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betamethasone-17-valerate 0.1% ointment
Trial: 19562253
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg of methylprednisolone pre-operatively
Trial: 25609939
Drug: Acetylcholinesterase inhibitors
RxNorm normalized name: acetylcholinesterase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetylcholinesterase inhibitors (AChEIs)
Trial: 17415706
Drug: Non-steroidal anti-inflammatory
RxNorm normalized name: Non-steroidal anti-inflammatory agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-steroidal anti-inflammatory compounds (rofecoxib)
Trial: 17415706
Drug: Sex steroid
RxNorm normalized name: Sex steroid binding globulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sex steroid hormones (testosterone, estrogens)
Trial: 15557906
Drug: Heparin-bonded Dacron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-bonded Dacron (HBD)
Trial: 22990217
Drug: 4-mg nicotine
RxNorm normalized name: nicotine 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-mg nicotine gum
Trial: 2626520
Drug: Oral fluphenazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fluphenazine (FLU)
Trial: 769555
Drug: Aspirin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (600 mg every 6 hours)
Trial: 20610466
Drug: Antihypertensive medication
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive medication adherence
Trial: 29991214
Drug: Sports therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sports therapy and recreation exercise program
Trial: 19692798
Drug: GW406381 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GW406381 25 mg
Trial: 19099009
Drug: GW406381 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GW406381 50 mg
Trial: 17876866
Drug: Bimosiamose disodium
RxNorm normalized name: BALSALAZIDE DISODIUM
DrugBank: Balsalazide (DB01014)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bimosiamose disodium 100 mg
Trial: 17876866
Drug: Bimosiamose disodium
RxNorm normalized name: BALSALAZIDE DISODIUM
DrugBank: Balsalazide (DB01014)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bimosiamose disodium 200 mg
Trial: 17876866
Drug: Bimosiamose disodium
RxNorm normalized name: BALSALAZIDE DISODIUM
DrugBank: Balsalazide (DB01014)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bimosiamose disodium 300 mg
Trial: 15497369
Drug: Antioxidant supplementation
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplementation (20,000 IU of beta-carotene, 400 IU alpha-tocopherol acetate, 500 mg ascorbic acid, 100 microg selenium, and 30 mg zinc)
Trial: 30086256
Drug: Topical pentoxifylline
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical pentoxifylline (PTX) 5% ointment, applied twice daily for 14 days
Trial: 19324483
Drug: Intravenous EPO
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous EPO administration
Trial: 19324483
Drug: Subcutaneous EPO
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous EPO administration
Trial: 16964676
Drug: Lamivudine 100
RxNorm normalized name: lamivudine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine 100 mg once daily for 48 weeks
Trial: 11111818
Drug: Prosorba Immunoadsorption
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prosorba Immunoadsorption Column treatment (active treatment arm)
Trial: 11111818
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment (apheresis only, control arm)
Trial: 9616826
Drug: Pristinamycin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pristinamycin (1 g bid for 10-14 days)
Trial: 9616826
Drug: Amoxicillin-clavulanic acid
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanic acid (500 mg q.i.d. for 10-14 days)
Trial: 1570887
Drug: Spinal anaesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anaesthesia with 12.5 mg hyperbaric 0.5% bupivacaine and postoperative immobilisation for either 6 or 24 hours.
Trial: 30677181
Drug: Anti-osteoporotic medications
RxNorm normalized name: pramoxine hydrochloride Medicated Pad [Scalpicin Anti-Itch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-osteoporotic medications
Trial: 24578135
Drug: Phosphate binder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphate binder therapy
Trial: 18839400
Drug: Generalized Anxiety
RxNorm normalized name: celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Generalized Anxiety Disorder Severity Scale (GADSS) administered via telephone
Trial: 17442467
Drug: Pnc polysaccharide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pnc polysaccharide vaccine, Hemophilus influenzae type b conjugate vaccine, and tetanus toxoid
Trial: 15921829
Drug: MC-4 vaccine
RxNorm normalized name: Adenovirus Type 4 Vaccine Live
DrugBank: Human adenovirus e serotype 4 strain cl-68578 antigen (DB14409)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MC-4 vaccine
Trial: 15194828
Drug: MPS-4 vaccine
RxNorm normalized name: Adenovirus Type 4 Vaccine Live
DrugBank: Human adenovirus e serotype 4 strain cl-68578 antigen (DB14409)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPS-4 vaccine
Trial: 15194828
Drug: Higher avidity
RxNorm normalized name: AVID-200
DrugBank: AVID-200 (DB18454)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher avidity antibody
Trial: 11115819
Drug: Oral glutamine
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral glutamine (18 g/day)
Trial: 8119688
Drug: ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ursodeoxycholic acid (13 to 15 mg/kg/day)
Trial: 27706121
Drug: Sensory Integration
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sensory Integration Therapy (SIT) for 2 weeks, 5 times a week
Trial: 31787369
Drug: Methylcobalamin 500
RxNorm normalized name: methylcobalamin 500 mcg oral lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylcobalamin 500 μg and folic acid 400 μg once daily
Trial: 27832260
Drug: Intravaginal testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal testosterone cream (IVT)
Trial: 27832260
Drug: Estradiol vaginal
RxNorm normalized name: Estradiol Vaginal
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol vaginal ring (7.5 μg/d)
Trial: 9869282
Drug: Overdenture supported
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overdenture supported by two IMZ implants (group A)
Trial: 9869282
Drug: Overdenture supported
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overdenture supported by four IMZ implants (group B)
Trial: 10841968
Drug: Salbutamol (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (8 mg slow-release, twice daily for 3 weeks)
Trial: 8396841
Drug: Oral estriol
RxNorm normalized name: Estriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estriol (3 mg/day for 4 weeks followed by 2 mg/day for a further 6 weeks)
Trial: 25939582
Drug: Cognitive-Behavioral Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Behavioral Therapy (Cool Kids CBT program)
Trial: 14503056
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy plus Tongxinluo (TXL) Capsule
Trial: 11018096
Drug: Chemotherapy regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy regimens from phase II studies with expected power of 0.62 and 0.58
Trial: 11018096
Drug: Chemotherapy regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy regimens from six other phase II studies
Trial: 3003020
Drug: Atenolol, 50
RxNorm normalized name: Atenolol, 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol, 50 mg once/day
Trial: 3003020
Drug: ICI 118551,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICI 118551, 20 mg 3 times/day
Trial: 22463944
Drug: Herbal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal treatment
Trial: 20144188
Drug: Patient-guided focussed
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-guided focussed medium-energy density ESWT treatments (3 sessions at weekly intervals)
Trial: 16167962
Drug: 6 hours
RxNorm normalized name: nitroglycerin 0.6 MG/HR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 hours administration of misoprostol
Trial: 16167962
Drug: 36-48 hours
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 36-48 hours administration of misoprostol
Trial: 12870373
Drug: Magnesium flush
RxNorm normalized name: T8 Keto Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium flush infusion into the aortic root before cross-clamp removal
Trial: 12870373
Drug: Placebo flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo flush infusion into the aortic root before cross-clamp removal
Trial: 10385632
Drug: UDCA therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA therapy (600 mg/d)
Trial: 8874423
Drug: One-ring treatment
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-ring treatment group (17 eyes)
Trial: 8874423
Drug: Two-ring treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-ring treatment group (8 eyes)
Trial: 1997518
Drug: Bromocriptine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (5 mg/day in trial I; 7.5-10 mg/day in trial II)
Trial: 31446992
Drug: Afatinib starting
RxNorm normalized name: Afatinib
DrugBank: Afatinib (DB08916)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Afatinib starting dose of 20 mg/day, with potential increase in 10 mg increments up to 50 mg/day
Trial: 26844688
Drug: Vitamin-D and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin-D and calcium replacement (800 IU Vitamin-D and 500 mg Calcium once daily)
Trial: 22008377
Drug: Zopiclone 5
RxNorm normalized name: zopiclone 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone 5 or 10 mg
Trial: 22008377
Drug: Ethanol 50
RxNorm normalized name: ethanol 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol 50 g
Trial: 17258104
Drug: Structured nursing
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured nursing intervention program including music therapy, drama, and group therapy
Trial: 12825865
Drug: Regular dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular dose of omeprazole (20 mg/day for 3 days)
Trial: 12825865
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of omeprazole (80 mg bolus + 8 mg/h infusion/day for 3 days)